The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Olaparib combined with abiraterone versus olaparib alone for patients with DNA-repair deficient metastatic castration-resistant prostate cancer after progressing on abiraterone: A multicenter, real-world study.
 
Jun Xie
No Relationships to Disclose
 
Guanjie Yang
No Relationships to Disclose
 
Baijun Dong
No Relationships to Disclose
 
Wei Chen
No Relationships to Disclose
 
Tingting Zhao
No Relationships to Disclose
 
Ruiliang Wang
No Relationships to Disclose
 
Lin Ye
No Relationships to Disclose
 
Longfei Huang
No Relationships to Disclose
 
Tongtong Liu
No Relationships to Disclose
 
Menghuan Zhang
No Relationships to Disclose
 
Wei Xue
No Relationships to Disclose
 
Bo Peng
No Relationships to Disclose
 
Xudong Yao
No Relationships to Disclose
 
Bin Yang
No Relationships to Disclose